SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 425 - Prospectuses and communications, business combinations:
SEC Accession No. 0001213900-21-051619
Filing Date
2021-10-06
Accepted
2021-10-06 16:51:42
Documents
3

Document Format Files

Seq Description Document Type Size
1 FORM 425 ea148496-425_cmlife3.htm 425 24795
2 GRAPHIC image_001.jpg GRAPHIC 8864
3 GRAPHIC image_002.jpg GRAPHIC 12190
  Complete submission text file 0001213900-21-051619.txt   55643
Mailing Address C/O CORVEX MANAGEMENT LP 667 MADISON AVENUE NEW YORK NY 10065
Business Address C/O CORVEX MANAGEMENT LP 667 MADISON AVENUE NEW YORK NY 10065 (212) 474 6724
CM Life Sciences III Inc. (Filed by) CIK: 0001843762 (see all company filings)

IRS No.: 861691173 | Fiscal Year End: 1231
Type: 425
SIC: 2834 Pharmaceutical Preparations

Mailing Address C/O CORVEX MANAGEMENT LP 667 MADISON AVENUE NEW YORK NY 10065
Business Address C/O CORVEX MANAGEMENT LP 667 MADISON AVENUE NEW YORK NY 10065 (212) 474 6724
CM Life Sciences III Inc. (Subject) CIK: 0001843762 (see all company filings)

IRS No.: 861691173 | Fiscal Year End: 1231
Type: 425 | Act: 34 | File No.: 001-40312 | Film No.: 211310244
SIC: 2834 Pharmaceutical Preparations